Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Fojo

Showing results (171-180 of 180) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 180 results.
AIDS and Behavior|October 16, 2020
Changing Patterns of Alcohol Use and Probability of Unsuppressed Viral Load Among Treated Patients with HIV Engaged in Routine Care in the United StatesCatherine R Lesko, Robin M Nance, Bryan Lau, et al.
Drug and Alcohol Dependence|March 25, 2022
The relationship of alcohol and other drug use during the COVID-19 pandemic among people with or at risk of HIV; A cross-sectional survey of people enrolled in Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO) cohortsJarratt D Pytell, Nicola M Shen, Jeanne C Keruly, et al.
Breast Cancer Research and Treatment|September 14, 2016
ANG1005 for breast cancer brain metastases: correlation between <sup>18</sup>F-FLT-PET after first cycle and MRI in response assessmentC C O'Sullivan, M Lindenberg, C Bryla, et al.
Drug and Alcohol Dependence|March 25, 2022
COVID-19 and the HIV continuum in people living with HIV enrolled in Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO) cohortsCatherine R Lesko, Jeanne C Keruly, Richard D Moore, et al.
Annals of Epidemiology|September 23, 2023
Impact of subgroup-specific heterogeneities and dynamic changes in mortality rates on forecasted population size, deaths, and age distribution of persons receiving antiretroviral treatment in the United States: a computer simulation studyParastu Kasaie, Cameron Stewart, Elizabeth Humes, et al.
European Journal of Cancer (Oxford, England : 1990)|March 21, 2025
Guidance for discussants of randomized cancer trials at major meetingsElizabeth A Eisenhauer, Omar Abdihamid, Christopher M Booth, et al.
Drug and Alcohol Dependence|November 4, 2022
Alcohol consumption upon direct-acting antiviral therapy for hepatitis C among persons with human immunodeficiency virus in the United StatesPo-Hung Chen, Karine Yenokyan, Anthony T Fojo, et al.
Nature Genetics|September 25, 2019
Reply to 'H-STS, L-STS and KRJ-I are not authentic GEPNET cell lines'Mariano J Alvarez, Pengrong Yan, Mary L Alpaugh, et al.
Science (New York, N.Y.)|January 17, 1997
An information-intensive approach to the molecular pharmacology of cancerJ N Weinstein, T G Myers, P M O'Connor, et al.
Cancer Research|July 1, 1996
Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendationsW T Beck, T M Grogan, C L Willman, et al.
Pageof 18

Showing results (171-180 of 180) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 180 results.
AIDS and Behavior|October 16, 2020
Changing Patterns of Alcohol Use and Probability of Unsuppressed Viral Load Among Treated Patients with HIV Engaged in Routine Care in the United StatesCatherine R Lesko, Robin M Nance, Bryan Lau, et al.
Drug and Alcohol Dependence|March 25, 2022
The relationship of alcohol and other drug use during the COVID-19 pandemic among people with or at risk of HIV; A cross-sectional survey of people enrolled in Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO) cohortsJarratt D Pytell, Nicola M Shen, Jeanne C Keruly, et al.
Breast Cancer Research and Treatment|September 14, 2016
ANG1005 for breast cancer brain metastases: correlation between <sup>18</sup>F-FLT-PET after first cycle and MRI in response assessmentC C O'Sullivan, M Lindenberg, C Bryla, et al.
Drug and Alcohol Dependence|March 25, 2022
COVID-19 and the HIV continuum in people living with HIV enrolled in Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO) cohortsCatherine R Lesko, Jeanne C Keruly, Richard D Moore, et al.
Annals of Epidemiology|September 23, 2023
Impact of subgroup-specific heterogeneities and dynamic changes in mortality rates on forecasted population size, deaths, and age distribution of persons receiving antiretroviral treatment in the United States: a computer simulation studyParastu Kasaie, Cameron Stewart, Elizabeth Humes, et al.
European Journal of Cancer (Oxford, England : 1990)|March 21, 2025
Guidance for discussants of randomized cancer trials at major meetingsElizabeth A Eisenhauer, Omar Abdihamid, Christopher M Booth, et al.
Drug and Alcohol Dependence|November 4, 2022
Alcohol consumption upon direct-acting antiviral therapy for hepatitis C among persons with human immunodeficiency virus in the United StatesPo-Hung Chen, Karine Yenokyan, Anthony T Fojo, et al.
Nature Genetics|September 25, 2019
Reply to 'H-STS, L-STS and KRJ-I are not authentic GEPNET cell lines'Mariano J Alvarez, Pengrong Yan, Mary L Alpaugh, et al.
Science (New York, N.Y.)|January 17, 1997
An information-intensive approach to the molecular pharmacology of cancerJ N Weinstein, T G Myers, P M O'Connor, et al.
Cancer Research|July 1, 1996
Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendationsW T Beck, T M Grogan, C L Willman, et al.
Pageof 18